Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

Details for Australian Patent Application No. 2008321253 (hide)

Owner The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services

Inventors Harris, Curtis C.; Lane, David P.; Vojtesek, Borivoj; Fujita, Kaori; Horikawa, Izumi; Bourdon, Jean-Christophe

Agent Pizzeys

Pub. Number AU-A-2008321253

PCT Pub. Number WO2009/064590

Priority 60/987,340 12.11.07 US

Filing date 21 October 2008

Wipo publication date 22 May 2009

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/064590 Priority application(s): WO2009/064590

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321255-Gas phase production of coated titania

2008321247-Methods for fabricating syngas cooler platens and syngas cooler platens